Summary
We have previously demonstrated that opiate-like substances in food protein (exorphins), contained in the peptic digest of gluten, stimulate insulin and glucagon release in dogs and that this effect is inhibited by the opiate antagonist naloxone. The present study was designed to evaluate the possible rôle of ingested opiate-like substances in the modulation of post-prandial insulin release. Similarly, the addition of synthetic β-casomorphins, which are the opioid-active material of bovine casein peptone, elicit a stimulation of post-prandial insulin release during a liver extract-sucrose test meal. The addition of met-enkephalin to a liver extract-sucrose test meal also augmented the post-prandial insulin response. Both stimulatory effects were reversed by oral naloxone, as was the post-prandial increase of insulin following ingestion of bovine casein peptone (casopeptone). The post-prandial insulin response to digested and undigested liver extract was not affected by naloxone, suggesting that the foregoing effects are likely to be specific to opiate-like materials contained in foodstuff (exorphins). In view of previous findings, the present data are compatible with a role of opiate-like substances contained in ingested nutrients in the regulation of post-prandial insulin secretion.
Article PDF
Similar content being viewed by others
References
Polak JM, Bloom SR, Sullivan SN, Facer P, Pearse AGE (1977) Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet 1: 972–974
Uddman R, Alumets J, Håkanson R, Sundler F, Walles B (1980) Peptidergic (enkephalin) innervation of the mammalian oesophagus. Gastroenterology 78: 732–737
Forssman WG, Helmstaedter V, Feurle G (1977) Relationship of enkephalin and endorphin immunoreactivity with D-cells and G-cells of the stomach. Hepatogastroenterology 24: 488–491
Bruni JF, Watkins WB, Yen SSC (1979) β-endorphin in the human pancreas. J Clin Endocrinol Metab 49: 649–651
Grube D, Voight KH, Weber E (1978) Pancreatic glucagon cells contain endorphin-like immunoreactivity. Histochemistry 59: 75–79
Larsson L (1979) Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin/CCK immunoreactive nerves. J Histochem Cytochem 27: 1283–1284
Ipp E, Dobbs R, Unger RH (1978) Morphine and β-endorphin influence the secretion of the endocrine pancreas. Nature 276: 190–191
Ipp E, Schusdziarra V, Harris V, Unger RH (1980) Morphine-induced hyperglycemia: role of insulin and glucagon. Endocrinology 107: 461–463
Green IC, Perrin D, Pedley KC, Leslie RDG, Pyke DA (1980) Effect of enkephalin and morphine on insulin secretion from isolated rat islets. Diabetologia 19: 158–161
Kanter RA, Ensinck JW, Fujimoto WY (1980) Disparate effects of enkephalin and morphine upon insulin and glucagon secretion on islet cell cultures. Diabetes 29: 84–86
Kachur JF, Miller RJ, Field M (1980) Control of guinea pig intestinal electrolyte secretion by an opiate receptor. Proc Natl Acad Sci 77: 2753–2756
Chey WY, Coy DH, Konturek SJ, Schally AV, Tasler J (1980) Enkephalin inhibits the release and action of secretin on pancreatic secretion in the dog. J Physiol 298: 429–436
Stubbs WA, Jones A, Edwards GRW, Delitala G, Jeffcoate WJ, Ratter SJ, Besser GM, Bloom SR, Alberti KGMM (1978) Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 2: 1225–1227
Riegel F (1900) Über den Einfluß des Morphiums auf die Magensaftsekretion. Z Klin Med 40: 347–350
Magee DF (1975) Action of morphine sulphate on stimulated gastric secretion in dogs. Gastroenterology 68: 1340–1343
Morley JE, Branetsky NG, Wingert TD, Carlson HE, Hershman JE, Melmed S, Levin SR, Jamison KR, Weitzman R, Chang RJ, Varner AA (1980) Endocrine effects of naloxone-induced opiate receptor blockade. J Clin Endocrinol Metab 50: 251–257
Reid RL, Yen SSC (1981) β-endorphin stimulates the secretion of insulin and glucagon in humans. J Clin Endocrinol Metab 52: 592–594
Feldman M, Walsh JH, Taylor IL (1980) Effect of naloxone and morphine on gastric acid secretion and on serum gastrin and pancreatic polypeptide concentrations in humans. Gastroenterology 79: 294–298
Zioudrou C, Streaty RA, Klee WA (1979) Opioid peptides derived from food proteins. J Biol Chem 254: 2446–2449
Brantl V, Teschemacher H, Henschen A, Lottspeich F (1979) Novel opioid peptides derived from casein (β-casomorphin). Hoppe Seylers Z Physiol Chem 360: 1211–1216
Brantl V, Teschemacher H (1979) A material with opioid activity in bovine milk and milk products. Naunyn Schmiedebergs Arch Pharmacol 303: 301–304
Hazum E, Sabatka JJ, Chang K, Brent DA, Findlay JWA, Cuatrecasas P (1981) Morphine in cow and human milk: could dietary morphine constitute a ligand for specific morphine receptors? Science 213: 1010–1012
Schusdziarra V, Henrichs I, Holland A, Klier M, Pfeiffer EF (1981) Evidence for an effect of exorphins on plasma insulin and glucagon levels in dogs. Diabetes 30: 362–364
Blumberg H, Dayton HB (1972) Naloxone and related compounds. In: Kosterlitz HW, Collier HOJ, Villareal JE (eds) Agonist and antagonist actions of narcotic analgesic drugs. Macmillan Press, London, pp 110–119
Herbert V, Lau LS, Gottlieb CW, Bleicher SF (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375–1384
Margules DL, Moisset B, Lewis MJ, Shibuya H, Pert CB (1978) β-endorphin is associated with over-eating in genetically obese mice (ob/ob) and rats (fa/fa). Science 202: 988–991
Brands B, Thornhill JA, Hirst M, Gowdey CW (1979) Suppression of food intake and body weight gain by naloxone in rats. Life Sciences 24: 1773–1778
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schusdziarra, V., Holland, A., Schick, R. et al. Modulation of post-prandial insulin release by ingested opiate-like substances in dogs. Diabetologia 24, 113–116 (1983). https://doi.org/10.1007/BF00297392
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00297392